Due to these results, the authors conclude that targeting the NEDD4L/RASGRP2 axis or inducing RASGRP2-modified ADMSCs exosomes could be a strategy for alleviating diabetes-related atherosclerosis. This evidence concerns the gene RASGRP2 and atherosclerosis.